Clinical Trial Update: Peri-operative Oral Triiodothyronine Replacement Therapy to Decrease the Risk of Transient Atrial Fibrillation After Off-pump Coronary Artery Bypass Surgery [NA]

View source ↗

Summary

A completed clinical trial evaluated perioperative oral triiodothyronine replacement to lower the risk of transient atrial fibrillation after off-pump coronary …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Non-thyroidal Illness Syndrome

Drugs mentioned

• Triiodothyronine (liothyronine sodium)

Snippet

Sponsor: Yonsei University | Conditions: Non-thyroidal Illness Syndrome | NA | Status: COMPLETED